Stock Market

The current narrative surrounding FuelCell Energy (NASDAQ:FCEL) stock revolves around a few central ideas.  Source: Kaca Skokanova/Shutterstock One, the idea that it will rise from President Joseph Biden’s infrastructure bill and the money to be directed toward clean energy. And two, that FCEL stock is a buy-the-dip opportunity.  Let’s start there first.  Opportunity? Early in
0 Comments
After months of consolidation, Bionano Genomics (NASDAQ:BNGO) is breaking down. BNGO stock has plummeted 30% since announcing earnings in early November. While the earnings report was decent, some legitimate concerns and a lack of news continue to weigh on shares. Source: Shutterstock / PopTika I’ll admit the genome analysis company is compelling, but investors should wait
0 Comments
This is big news if you’re a fan of investor Cathie Wood. Reportedly, Wood’s company, Ark Invest, on Oct. 27  purchased more than 2.1 million shares of online mobile gaming technology platform Skillz (NYSE:SKLZ). So does Wood’s move  mean that you should buy SKLZ stock, too? Source: NYCStock / Shutterstock.com Not necessarily. Every investor has different reasons
0 Comments
Data center real estate investment trusts (REITs) like Equinix (NASDAQ:EQIX) stock are a hot ticket right now. CyrusOne (NASDAQ:CONE) was bought out by private equity, led by KKR (NYSE:KKR), or Coresite Realty (NYSE:COR) which is being bought by American Tower (NYSE:AMT). Source: Ken Wolter / Shutterstock.com Earlier this year, QTS Realty Trust was taken out
0 Comments
The stock market is full of ups and downs, which isn’t necessarily a bad thing. Shares of clinical-stage biotechnology company Cassava Sciences (NASDAQ:SAVA) are prone to peaks and valleys, but this means that you can trade SAVA stock profitably if you have good timing. Source: Pavel Kapysh / Shutterstock.com Don’t get the wrong idea — you
0 Comments
An opportunity may be coming to buy Costco Wholesale (NASDAQ:COST) stock. Investors are selling stocks in the biggest retailers, even as they report blowout earnings. If the pattern holds after Costco reports Dec. 9 earnings, you may be able to get some for Christmas. Source: ilzesgimene / Shutterstock.com As trading opened Nov. 19, Costco was
0 Comments
What’s the first thing that comes to mind when you hear the word “metaverse”? If it’s an immersive virtual reality world that looks like something out of the science fiction movie Ready Player One, then you’re not alone. That’s pretty much what everyone thinks of when they think of the metaverse. Source: Kathy Hutchins /
0 Comments
In a record blitz of initial public offerings (IPO) like Progenity (NASDAQ:PROG), you’re going to encounter two incontrovertible facts. First, retail investors will have increased opportunities to put their money to work (or at risk). Second, not every one of these recent IPOs will enjoy outsized success. From the looks of it, PROG stock is heading
0 Comments
Why COCO Stock Is a Rare Low-Tech Growth Name | InvestorPlace Skip to content Copyright © 2021 InvestorPlace Media, LLC. All rights reserved. 1125 N. Charles St, Baltimore, MD 21201. COCO stock has a low valuation, but Vita Coco is growing rapidly November 17, 2021 By Larry Ramer, InvestorPlace Contributor Nov 18, 2021, 6:00 am
0 Comments
ContextLogic (NASDAQ:WISH) operates Wish, an e-commerce platform that facilitates transactions between sellers and buyers, focusing on the budget-conscious consumer. Founded by Piotr Szulczewski and Danny Zhang back in 2010, this company has grown rapidly due to its innovative business strategies and easy-to-use platform. However, due to issues surrounding quality on the platform and wider reopenings,
0 Comments
Shares of all-electric pickup truck maker Rivian Automotive (NASDAQ:RIVN) continue to soar on the heels of a spectacular first week. After pricing at $78, RIVN stock now trades at $172 per share — a spectacular 120% gain. Sporting a $152 billion market capitalization, Rivian is the biggest initial public offering (IPO) of the year. It’s also
0 Comments
The chase continues for the two important contingents propping up Ocugen (NASDAQ:OCGN) stock at present. Source: shutterstock.com/PhotobyTawat On the one hand, there’s those who hope Ocugen can finally break through and receive approval to market its Covaxin vaccine. But that hope has followed the company for a long time and provided plenty of disappointment. Nevertheless,
0 Comments